Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin-deethylation by fluvoxamine

Author: Sy Sherwin   Tang Bing-Kou   Pastrakuljic Aleksandra   Roberts Eve   Kalow Werner  

Publisher: Springer Publishing Company

ISSN: 0031-6970

Source: European Journal of Clinical Pharmacology, Vol.57, Iss.5, 2001-08, pp. : 377-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next